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hypertrophy. Furthermore, ET1 mediated its effects indirectly via
NE in CM-SN co-cultures through adrenergic receptors and histone
deacetylases, resulting in activation of the pro-hypertrophic transcrip-
tion factorMEF2. In conclusion, sympathetic ETA ampliﬁes ET1 effects on
CMs through adrenergic neurotransmission. In accordance to our initial
hypothesis, anti-adrenergic therapies may blunt potential beneﬁcial
effects of ETAi. These ﬁndings call for a personalized strategy to identify
patients that could beneﬁt from ETAi.
doi:10.1016/j.lfs.2013.12.191
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The murine homologue to human chymase, the mouse Mast Cell
Protease-4 (mMCP-4), activates the pro-forms of angiotensin-II and
endothelin-1 (ET-1) in vivo; both peptides being well-established in
cardiovascular diseases. In the present study we postulated that mMCP-
4-dependent synthesis of ET-1 plays an important role in the
development of atherosclerosis in the Apolipoprotein E knock out
mouse model (ApoE KO). Peritoneal mast cells were collected from
C56BL/6J wild-type (WT), mMCP-4 KO and ApoE KO mice and their
granular contents were assayed for the enzymatic processing of the
ﬂuorogenic substrate Suc-Val-Val-Pro-Phe-amidomethylcoumarin. WT
and ApoE KO derived samples produced a TY-51469 (speciﬁc chymase
inhibitor) sensitive ﬂuorescence, but not in mMCP-4 KO samples.
Via HPLC detection, a TY-51469-sensitive conversion of big ET-1 to ET-
1 (1-31)wasmonitored inmast cell homogenates. Homogenate samples
from ApoE KO mice showed signiﬁcant increases in ET-1 (1-31)
production when compared to extracts from WT mice (milliAU × time
(s), WT: 763 ± 124; ApoE KO: 1756 ± 339, n = 7; P= 0.018). Finally,
Sudan IV staining of aortas from 27 to 30 week old male mice on chow
diet showed that the repression of mMCP-4 in APOE KO mice (APOE/
mMCP-4 dKO) reduced by 65% the atherosclerotic lesion area found in
ApoE KO mice (ApoE KO: 7.45 ± 1.31%; ApoE/mMCP-4 dKO: 2.67 ±
0.64%, n = 9–10, P = 0.004). These results suggest an increased con-
tribution role of mMCP-4 in the synthesis of ET-1 in mast cells derived
from ApoE KO mice and the pivotal role of that chymase isoform in the
development of atherosclerosis. (Funded by CIHR).
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